Wealth Quarterback’s Idexx Laboratories IDXX Stock Holding History

Wealth Quarterback’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263K	Hold	500	–	–	0.08%	150
2026 Q1	$281K	Hold	500	–	–	0.11%	134
2025 Q4	$338K	Hold	500	–	–	0.12%	115
2025 Q3	$319K	Hold	500	–	–	0.12%	122
2025 Q2	$268K	Hold	500	–	–	0.13%	113
2025 Q1	$210K	Hold	500	–	–	0.12%	116
2024 Q4	$207K	Hold	500	–	–	0.1%	113
2024 Q3	$253K	Hold	500	–	–	0.13%	103
2024 Q2	$244K	Hold	500	–	–	0.14%	101
2024 Q1	$270K	Hold	500	–	–	0.15%	95
2023 Q4	$278K	Hold	500	–	–	0.17%	95
2023 Q3	$219K	Hold	500	–	–	0.19%	96
2023 Q2	$251K	Hold	500	–	–	0.17%	94
2023 Q1	$250K	Hold	500	–	–	0.21%	93
2022 Q4	$204K	Buy	+500	New	+$194K	0.17%	105
2021 Q3	$311K	Hold	500	–	–	0.21%	82
2021 Q2	$316K	Buy	+500	New	+$276K	0.19%	85
2020 Q4	$250K	Buy	+500	New	+$224K	0.21%	91
2020 Q2	–	Sell	-500	Closed	-$121K	–	407
2020 Q1	$121K	Hold	500	–	–	0.11%	140
2019 Q4	$131K	Buy	+500	New	+$132K	0.11%	137

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Wealth Quarterback's IDXX Position: Q2 2026 in Review

Wealth Quarterback held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 500 shares worth $263K. The position accounts for 0.08% of the portfolio, ranked #150.

Wealth Quarterback first reported a position in IDXX in Q4 2019 and has held it in 20 quarters since. The position peaked at $338K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Wealth Quarterback held 500 shares of Idexx Laboratories worth $263K as of Q2 2026.
Wealth Quarterback left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.08% of Wealth Quarterback's portfolio in Q2 2026, its #150 holding.
Wealth Quarterback first reported a position in Idexx Laboratories in Q4 2019 and has held it in 20 quarters since.
Wealth Quarterback's Idexx Laboratories position peaked at $338K in Q4 2025.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Wealth Quarterback's 13F filing for Q2 2026, filed 27 Jul 2026.